The estimated Net Worth of Mary Fisher is at least $2.14 Milhão dollars as of 2 July 2007. Ms. Fisher owns over 7,500 units of Sientra Inc stock worth over $9,729 and over the last 19 years she sold SIEN stock worth over $1,795,177. In addition, she makes $334,182 as Independent Director at Sientra Inc.
Sign up
Ms. Fisher SIEN stock SEC Form 4 insiders trading
Mary has made over 10 trades of the Sientra Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently she sold 7,500 units of SIEN stock worth $132,525 on 2 July 2007.
The largest trade she's ever made was selling 40,000 units of Sientra Inc stock on 6 November 2006 worth over $642,000. On average, Mary trades about 3,125 units every 7 days since 2006. As of 2 July 2007 she still owns at least 57,230 units of Sientra Inc stock.
You can see the complete history of Ms. Fisher stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mary Fisher biography
Mary M. Fisher serves as Independent Director of the Company. Ms. Fisher has served as a director of the Company since January 2019. Ms. Fisher currently serves as Chief Executive Officer, Chair and Board Director at Colorescience, a science-based skincare company and former division of SkinMedica, Inc. While at SkinMedica, she served as Chief Executive Officer from 2008 to 2012, when she led the successful sale of the company to Allergan, Inc. Prior to joining SkinMedica, Ms. Fisher served as the Chief Operating Officer of Acorda Therapeutics, a biotechnology company. She has previously held management and leadership positions at Cephalon, Immunex, and Boehringer Ingelheim. She previously served on the Board of Directors at ZELTIQ Aesthetics, Inc. and Ovascience and currently sits on the Board of MDRejuvena. In 2013, Ms. Fisher was honored as Ernst & Young's Entrepreneur of the Year for San Diego and also received the EY Venture Capital Award of Excellence. Ms. Fisher was also named a finalist for Most Admired CEO by the San Diego Business Journal in 2018.
What is the salary of Mary Fisher?
As the Independent Director of Sientra Inc, the total compensation of Mary Fisher at Sientra Inc is $334,182. There are 3 executives at Sientra Inc getting paid more, with Jeffrey Nugent having the highest compensation of $3,015,280.
How old is Mary Fisher?
Mary Fisher is 57, she's been the Independent Director of Sientra Inc since 2019. There are 4 older and 2 younger executives at Sientra Inc. The oldest executive at Sientra Inc is Jeffrey Nugent, 72, who is the Chairman of the Board, Chief Executive Officer.
What's Mary Fisher's mailing address?
Mary's mailing address filed with the SEC is 3333 MICHELSON DRIVE, SUITE 650, IRVINE, CA, 92612.
Insiders trading at Sientra Inc
Over the last 10 years, insiders at Sientra Inc have traded over $15,843,498 worth of Sientra Inc stock and bought 1,651,210 units worth $23,354,020 . The most active insiders traders include Llp Abingworth, Advisors Llc Orbi Med Capit..., eTimothy Haines. On average, Sientra Inc executives and independent directors trade stock every 73 days with the average trade being worth of $17,193. The most recent stock trade was executed by Ronald Menezes on 10 November 2021, trading 78,498 units of SIEN stock currently worth $445,084.
What does Sientra Inc's logo look like?
Complete history of Ms. Fisher stock trades at Acorda Therapeutics Inc e Sientra Inc
Sientra Inc executives and stock owners
Sientra Inc executives and other stock owners filed with the SEC include:
-
Jeffrey Nugent,
Chairman of the Board, Chief Executive Officer -
Paul Little,
Chief Financial Officer, Senior Vice President, Treasurer -
Keith Sullivan,
Director -
Mary Fisher,
Independent Director -
Philippe Schaison,
Independent Director -
Nicholas Simon,
Lead Independent Director -
Kevin O'Boyle,
Independent Director -
Caroline Van Hove,
Independent Director -
R Scott Greer,
Director -
Matthew Pigeon,
CFO and Treasurer -
Hani M Zeini,
Director -
Advisors Llc Orbi Med Capit...,
-
Alexander W. Casdin,
Director -
Charles Huiner,
COO & SVP Corp. Dev. Strategy -
Patrick F. Williams,
General Manager miraDry & SVP -
Llp Abingworth,
10% owner -
Timothy Haines,
Director -
Oliver Christian Bennett,
GC & Chief Compliance Officer -
Valerie J Miller,
VP, Controller and Interim CFO -
Nori Ebersole,
Director -
Andrew C Schmidt,
Chief Financial Officer -
Irina Erenburg,
Director -
Ronald Menezes,
President and CEO